Ant Group Unveils Major Upgrades to Its Full-Suite AI Solutions in Healthcare for Hospitals, Doctors and Users
Ant Group works with industry partners to integrate its healthcare large model with a range of All-in-One Large Model Machines for Healthcare, which are already being adopted by leading hospitals in China.Its AI Doctor Assistant and AI Healthcare Manager have also received major upgrades to enhance user experience.
Ant Group has announced major upgrades to its comprehensive suite of AI solutions for the healthcare sector, aiming to enhance the capabilities of hospitals and doctors, and collaboratively benefit users through advanced AI innovations.
Empowering Hospitals with Secure and Efficient AI Integration
As industries increasingly adopt AI technologies, hospitals are leveraging latest innovations, including large models, to streamline operations and enhance patient care. To better support its healthcare service partners and with its extensive industry knowledge and technical expertise, Ant Group has collaborated with IT industry leaders to integrate its advanced healthcare large model into various types of All-in-One Large Model Machine for Healthcare. This solution allows hospitals to deploy AI models on-premises, ensuring efficient and secure use of AI to optimize daily operations and improve patient services. To date, the solution has already been adopted by seven leading hospitals and healthcare institutions across Beijing, Shanghai, Hangzhou, and Ningbo.
Being built on advanced foundation models including DeepSeek R1/V3, Alibaba’s Qwen, and Ant Group’s self-developed BaiLing, Ant Group’s healthcare large model is equipped with medical reasoning and multimodal interaction capabilities, and has consecutively won first place in several categories, including medical knowledge Q&A, in the MedBench evaluation of medical models.
The all-in-one machines also benefit from Ant Group’s privacy-preserving computation solution, which safeguards data privacy and ensures traceability, enabling secure and mutually trusted collaboration between hospitals and other stakeholders.
Beyond the backend technological support, Ant Group is also helping hospitals develop user-facing applications. Angel, an AI agent developed in collaboration with public medical institutions in China’s Zhejiang Province, has served over 1,000 medical facilities, handling more than 30 million user interactions. Additionally, Ant Group has supported local basic medical insurance services across China in developing Yibaoer, an AI agent designed to assist users with medical insurance-related inquiries.
Upgraded AI Doctor Assistant for Advanced Research
In January 2025, Ant Group completed the acquisition of Haodf, a leading healthcare platform focused on online doctor consultations. This acquisition strengthens Ant Group’s commitment to innovating AI-powered healthcare solutions. Together, Ant Group and Haodf launched the AI Doctor Assistant to support the platform’s 290,000 doctors with tasks such as patient education and medical record management.
The assistant has now been upgraded to support scientific research by integrating DeepSeek, helping doctors quickly locate relevant research articles and providing comprehensive summaries. It also offers AI-assisted diagnoses based on patient records and medical reports, citing relevant research articles to support doctors in their decision-making process.
Enhanced AI Healthcare Manager for Individual Users’ Personalized Services
In September 2024, Ant Group launched the AI Healthcare Manager within the Alipay app. Available through voice and text conversations, this healthcare manager connects users to over 30 services, including doctor mapping, medical report interpretation, in-hospital navigation, and personalized medical advice. Since its launch, the AI Healthcare Manager has assisted 40 million users.
The latest upgrade brings more detailed and personalized health advice. New features include health status self-detection and medical report analysis, offering users a comprehensive approach to managing their well-being.
Since 2014, Ant Group has been supporting the digital and intelligent transformation of China’s healthcare sector to fulfill the growing demands of its population, helping medical institutions, doctors and health insurers provide more efficient, accessible, and personalized services for all users.
Ant Insurance, Ant Group's online insurance brokerage platform, has supported leading insurers in providing more accessible insurance services. In 2024, insurers in China processed 7.25 million health claims through Ant Insurance, marking a 55% year-over-year increase, driven by ongoing innovations in product offerings and user experience.
Five years ago, with the introduction of China’s Medical Insurance Code—the e-certificate for basic medical insurance—Chinese citizens no longer needed to carry a physical medical insurance card when visiting hospitals or drugstores. By the end of 2024, over 700 million people had activated their e-certificates via Alipay.
About Ant Group
Ant Group aims to build the infrastructure and platforms to support the digital transformation of the service industry. Through continuous innovation, we strive to provide all consumers and small and micro businesses equal access to digital financial and other daily life services that are convenient, sustainable and inclusive.
For more information, please visit our website at www.antgroup.com or follow us on Twitter @AntGroup.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250324985498/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Murata Automotive-Compliant Chip Ferrite Beads Deliver Wide Band Noise Suppression of High-Frequency (5.9GHz) C-V2X19.6.2025 04:00:00 CEST | Press release
The new BLM15VM series is ideal for automotive powertrains and safety applications. It supports high frequencies. 1000Ω (Typ.) @5.9GHz. With its compact 0402-inch size (1.0×0.5mm) can operate at temperatures ranging from -55 to 150°C. And it is compliant with AEC-Q200. Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) continues to push the envelope in automotive noise suppression technology with another industry first. By leveraging proprietary material technology and optimized structural design, the company’s new BLM15VM series of automotive-compliant chip ferrite beads deliver wide-band noise suppression of high-frequency (5.9GHz) 5G vehicle-to-everything (5G-V2X) applications that exhibit high impedance. Mass production is scheduled to begin in July 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618511573/en/ [Murata Manufacturing Co., Ltd.] New Chip Ferrite Beads for Automotive In recent years, t
AV and UAS Denmark Establish Strategic Partnership to Advance Allied UAS Capabilities in Europe18.6.2025 22:30:00 CEST | Press release
AeroVironment, Inc. (“AV”) (NASDAQ: AVAV) today announced it has signed a Memorandum of Understanding (MOU) with Hans Christian Andersen Aiport in Odense, Denmark–home to the UAS Denmark Test Center–to explore joint utilization of the center’s expansive airspace and advanced test facilities. The agreement aims to leverage UAS Denmark’s strategic range and infrastructure to support AV’s uncrewed aircraft system (UAS) demonstration operations, mission training, and customer integration activities across the region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618380337/en/ JUMP 20 executes a seamless landing on a moving ship (Photo: AV) The collaboration is expected to enable joint research and development (R&D) initiatives and accelerate the growth of the UAS Denmark Test Center as a regional epicenter for advanced UAS innovation, evaluation, and operational readiness. "This MOU represents a significant milestone in expa
Stone Harbor Investment Partners Introduces Emerging Markets Climate Impact Debt Fund18.6.2025 22:05:00 CEST | Press release
Actively managed, sustainable UCITS fund targets emerging market countriesThis is a marketing communication. Stone Harbor Investment Partners, an investment manager of Virtus Investment Partners, Inc. (NYSE: VRTS), has launched the Stone Harbor Emerging Markets Climate Impact Debt (Bloomberg: STHEMDI) (the “Fund”), a UCITS fund classified as Article 9 under the Sustainable Finance Disclosure Regulation (SFDR) that addresses decarbonization efforts occurring in Emerging Markets (EM) while seeking to deliver attractive long-term total returns for investors. The Fund invests in sustainable debt issued with proceeds dedicated to environmental activities, assets, projects or expenditures, with social bonds also permissible, of EM corporate, sovereign, quasi-sovereign and supranational issuers in hard currency. The Fund, with a sustainable objective to promote the transition towards an environmentally and socially sustainable economy, seeks to outperform the J.P Morgan EM Credit Green, Socia
Incyte Announces FDA Approval of Monjuvi® (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma18.6.2025 21:39:00 CEST | Press release
- Monjuvi® (tafasitamab-cxix) in combination with rituximab and lenalidomide is the first FDA-approved CD19- and CD20-targeted immunotherapy combination for adult patients with follicular lymphoma (FL) - Patients with relapsed or refractory FL achieved significantly improved progression-free survival with Monjuvi in combination with rituximab and lenalidomide in the Phase 3 registration trial - This milestone represents the second approved indication for Monjuvi in the United States Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Monjuvi® (tafasitamab-cxix), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, in combination with rituximab and lenalidomide for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250615896694/en/ MONJUVI logo "Patients living with relapsed or refr
Andersen Consulting fortsætter sin globale udvidelse med tilføjelsen af Azurian Consulting18.6.2025 19:49:00 CEST | Pressemeddelelse
Andersen Consulting styrker sine evner inden for virksomhedstransformation, teknologi og kunstig intelligens via en samarbejdsaftale med Azurian Consulting. Azurian Consulting, der blev grundlagt i 2012, tilbyder en omfattende række af tjenester, herunder transformation af digital strategi, databaseret strategi, optimering af forretningsprocesser og forandringsledelse. Med base i Latinamerika hjælper Azurian Consulting kunder inden for en bred vifte af brancher såsom finansverdenen, detailhandel, forbrugervarer og fremstillingsindustrien. "Samarbejdet med Andersen Consulting åbner døren til nye markeder, styrker vores evne til at hjælpe multinationale kunder og giver vores team adgang til globale ressourcer," udtaler Nicolás Dueñas, der er administrerende direktør for Azurian Consulting. "Det repræsenterer en stærk synergi, der giver os mulighed for at kombinere vores regionale indsigt med Andersen Consultings globale platform og dermed styrke vores evne til at levere integrerede og sa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom